The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Epilepsy Diagnosis & Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease.
The global Epilepsy Diagnosis & Treatment market size is expected to reach US$ 21010 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Epilepsy Diagnosis & Treatment in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Epilepsy Diagnosis & Treatment market. Diagnosis (Neurological Exam, Blood Test, Imaging), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment (Medication, Surgery) segment is estimated at % CAGR for the next seven-year period.
Increasing prevalence of epilepsy is a major driver for the market. According to a report by the World Health Organization (2018), about 50 million people across the world are estimated to suffer from epilepsy, making it one of the most common neurological diseases. In addition, the report states that the total number of people aged 65 or more is projected to increase from 524 million in 2010 to approximately 1.5 billion by 2050.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Epilepsy Diagnosis & Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Epilepsy Diagnosis & Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Epilepsy Diagnosis & Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Epilepsy Diagnosis & Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Epilepsy Diagnosis & Treatment covered in this report include Pfizer, Johnson & Johnson, UCB Pharma, Abbott, GlaxoSmithKline, Novartis, Sanofi, Takeda and Medtronic, etc.
The global Epilepsy Diagnosis & Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson & Johnson
UCB Pharma
Abbott
GlaxoSmithKline
Novartis
Sanofi
Takeda
Medtronic
Natus Medical
Siemens
Global Epilepsy Diagnosis & Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Epilepsy Diagnosis & Treatment market, Segment by Type:
Diagnosis (Neurological Exam, Blood Test, Imaging)
Treatment (Medication, Surgery)
Global Epilepsy Diagnosis & Treatment market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Epilepsy Diagnosis & Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease.
The global Epilepsy Diagnosis & Treatment market size is expected to reach US$ 21010 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Epilepsy Diagnosis & Treatment in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Epilepsy Diagnosis & Treatment market. Diagnosis (Neurological Exam, Blood Test, Imaging), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treatment (Medication, Surgery) segment is estimated at % CAGR for the next seven-year period.
Increasing prevalence of epilepsy is a major driver for the market. According to a report by the World Health Organization (2018), about 50 million people across the world are estimated to suffer from epilepsy, making it one of the most common neurological diseases. In addition, the report states that the total number of people aged 65 or more is projected to increase from 524 million in 2010 to approximately 1.5 billion by 2050.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Epilepsy Diagnosis & Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Epilepsy Diagnosis & Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Epilepsy Diagnosis & Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Epilepsy Diagnosis & Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Epilepsy Diagnosis & Treatment covered in this report include Pfizer, Johnson & Johnson, UCB Pharma, Abbott, GlaxoSmithKline, Novartis, Sanofi, Takeda and Medtronic, etc.
The global Epilepsy Diagnosis & Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson & Johnson
UCB Pharma
Abbott
GlaxoSmithKline
Novartis
Sanofi
Takeda
Medtronic
Natus Medical
Siemens
Global Epilepsy Diagnosis & Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Epilepsy Diagnosis & Treatment market, Segment by Type:
Diagnosis (Neurological Exam, Blood Test, Imaging)
Treatment (Medication, Surgery)
Global Epilepsy Diagnosis & Treatment market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Epilepsy Diagnosis & Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Epilepsy Diagnosis & Treatment
1.1 Epilepsy Diagnosis & Treatment Market Overview
1.1.1 Epilepsy Diagnosis & Treatment Product Scope
1.1.2 Epilepsy Diagnosis & Treatment Market Status and Outlook
1.2 Global Epilepsy Diagnosis & Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Epilepsy Diagnosis & Treatment Market Size by Region (2018-2029)
1.4 Global Epilepsy Diagnosis & Treatment Historic Market Size by Region (2018-2023)
1.5 Global Epilepsy Diagnosis & Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Epilepsy Diagnosis & Treatment Market Size (2018-2029)
1.6.1 North America Epilepsy Diagnosis & Treatment Market Size (2018-2029)
1.6.2 Europe Epilepsy Diagnosis & Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size (2018-2029)
1.6.4 Latin America Epilepsy Diagnosis & Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size (2018-2029)
2 Epilepsy Diagnosis & Treatment Market by Type
2.1 Introduction
2.1.1 Diagnosis (Neurological Exam, Blood Test, Imaging)
2.1.2 Treatment (Medication, Surgery)
2.2 Global Epilepsy Diagnosis & Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Epilepsy Diagnosis & Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Epilepsy Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Epilepsy Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Epilepsy Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Epilepsy Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Epilepsy Diagnosis & Treatment Revenue Breakdown by Type (2018-2029)
3 Epilepsy Diagnosis & Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Epilepsy Diagnosis & Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Epilepsy Diagnosis & Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Epilepsy Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Epilepsy Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Epilepsy Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Epilepsy Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Epilepsy Diagnosis & Treatment Revenue Breakdown by Application (2018-2029)
4 Epilepsy Diagnosis & Treatment Competition Analysis by Players
4.1 Global Epilepsy Diagnosis & Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epilepsy Diagnosis & Treatment as of 2022)
4.3 Date of Key Players Enter into Epilepsy Diagnosis & Treatment Market
4.4 Global Top Players Epilepsy Diagnosis & Treatment Headquarters and Area Served
4.5 Key Players Epilepsy Diagnosis & Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Epilepsy Diagnosis & Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.1.4 Pfizer Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.2.4 Johnson & Johnson Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 UCB Pharma
5.3.1 UCB Pharma Profile
5.3.2 UCB Pharma Main Business
5.3.3 UCB Pharma Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.3.4 UCB Pharma Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Recent Developments
5.4 Abbott
5.4.1 Abbott Profile
5.4.2 Abbott Main Business
5.4.3 Abbott Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.4.4 Abbott Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Recent Developments
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business
5.5.3 GlaxoSmithKline Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.5.4 GlaxoSmithKline Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 GlaxoSmithKline Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.6.4 Novartis Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.7.4 Sanofi Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
5.8 Takeda
5.8.1 Takeda Profile
5.8.2 Takeda Main Business
5.8.3 Takeda Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.8.4 Takeda Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Takeda Recent Developments
5.9 Medtronic
5.9.1 Medtronic Profile
5.9.2 Medtronic Main Business
5.9.3 Medtronic Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.9.4 Medtronic Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Medtronic Recent Developments
5.10 Natus Medical
5.10.1 Natus Medical Profile
5.10.2 Natus Medical Main Business
5.10.3 Natus Medical Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.10.4 Natus Medical Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Natus Medical Recent Developments
5.11 Siemens
5.11.1 Siemens Profile
5.11.2 Siemens Main Business
5.11.3 Siemens Epilepsy Diagnosis & Treatment Products, Services and Solutions
5.11.4 Siemens Epilepsy Diagnosis & Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Siemens Recent Developments
6 North America
6.1 North America Epilepsy Diagnosis & Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Epilepsy Diagnosis & Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Epilepsy Diagnosis & Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Epilepsy Diagnosis & Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Epilepsy Diagnosis & Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Epilepsy Diagnosis & Treatment Market Dynamics
11.1 Epilepsy Diagnosis & Treatment Industry Trends
11.2 Epilepsy Diagnosis & Treatment Market Drivers
11.3 Epilepsy Diagnosis & Treatment Market Challenges
11.4 Epilepsy Diagnosis & Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
